Aries Wealth Management’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.5K Hold
12,500
0.01% 238
2026
Q1
$30.9K Hold
12,500
0.01% 230
2025
Q4
$25.6K Hold
12,500
0.01% 229
2025
Q3
$43.4K Sell
12,500
-1,000
-7% -$2.79K 0.01% 230
2025
Q2
$29.7K Sell
13,500
-350
-3% -$573 0.01% 216
2025
Q1
$16.1K Hold
13,850
﹤0.01% 222
2024
Q4
$17.6K Hold
13,850
﹤0.01% 219
2024
Q3
$47.2K Hold
13,850
0.01% 227
2024
Q2
$64.7K Buy
+13,850
New +$78.1K 0.02% 199
2021
Q3
Sell
-4,000
Closed -$227K 181
2021
Q2
$227K Buy
+4,000
New +$148K 0.1% 163
2021
Q1
Sell
-4,000
Closed -$362K 178
2020
Q4
$362K Buy
+4,000
New +$164K 0.18% 108

Other funds holding EDIT

Aries Wealth Management's EDIT Position: Q2 2026 in Review

Aries Wealth Management held its Editas Medicine (EDIT) position steady in Q2 2026 at 12,500 shares worth $40.5K. The position accounts for 0.01% of the portfolio, ranked #238.

Aries Wealth Management first reported a position in EDIT in Q4 2020 and has held it in 11 quarters since. The position peaked at $362K in Q4 2020. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Aries Wealth Management held 12,500 shares of Editas Medicine worth $40.5K as of Q2 2026.
  • Aries Wealth Management left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up 0.01% of Aries Wealth Management's portfolio in Q2 2026, its #238 holding.
  • Aries Wealth Management first reported a position in Editas Medicine in Q4 2020 and has held it in 11 quarters since.
  • Aries Wealth Management's Editas Medicine position peaked at $362K in Q4 2020.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Aries Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.